Singapore | English 中文 |
Bangladesh | English |
India | English |
Indonesia | English Bahasa |
Malaysia | English 中文 |
Myanmar | English Burmese |
Philippines | English |
Sri Lanka | English |
UAE | English Arabic |
Vietnam | English Tiếng Việt |
"Hi Doc" CME Empowerment Series 2024
“Hi Doc” Continuing Medical Education (CME) Empowerment Series II aims to provide a symptomatic approach to understanding common ailments for medical professionals to acquire, share and exchange knowledge & clinical experience.
In addition to knowledge sharing, a bigger objective is to forge working relationships, build a vibrant doctor community and strengthen competencies in the delivery of patient care.
Prostate cancer is the most common cancer in Singaporean men and there has been an increasing incidence of prostate cancer over the last few decades.
There are usually no symptoms in the early stages of prostate cancer and most men discover they have prostate cancer during routine medical check-ups or through blood tests.
In this “Hi Doc” CME Series II, we’ll be learning to recognise and diagnose prostate cancer as well as understanding the management of prostate cancer, including in its advanced stage.
We will share the latest technology used in the treatment of Prostate Cancer and also discuss post prostatectomy urinary incontinence in this forum.
Speakers
Senior Consultant
Medical Oncology
Parkway Cancer Centre
Senior Consultant
Urologist
Urohealth Medical Clinic
Senior Consultant
Urologist
Urohealth Medical Clinic
This CME event is organised with Urohealth Medical Clinic and supported by Ipsen.
DATE
Saturday, 31 August 2024
TIME
2PM - 3PM SGT
FORMAT
Hybrid Event
PHYSICAL MEETING REGISTRATION*
*Lunch will be served at 1pm. Seats are limited.
Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterised by the absence of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) receptors expression.
TNBC is a challenging subtype to manage as it tends to be more aggressive with a high likelihood of metastatic disease.
In this session, we will share how patients with TNBC present and how the diagnosis is made. We will also discuss the multidisciplinary management options of TNBC.
Speakers
Senior Consultant
Medical Oncology
Parkway Cancer Centre
Senior Consultant
Radiation Oncology
Parkway Cancer Centre
Director, Senior Consultant
General Surgeon
FeM Surgery
This CME event is organised with FeM Surgery and supported by MSD.
DATE
Saturday, 24 August 2024
TIME
2PM - 3PM SGT
FORMAT
Hybrid Event
PHYSICAL MEETING REGISTRATION*
*Lunch will be served at 1pm. Seats are limited.
Abdominal imaging are performed for a variety of reasons and can lead to incidental findings of kidney mass(es). Kidney mass(es) may range from benign (cysts, angiomyolipoma) to malignant and tend to be asymptomatic until the size becomes very large.
Renal cell carcinoma (RCC) accounts for 9 in 10 malignant kidney cancers and is twice as common in men than in women, with peak incidence between the 6th to 8th decades of life. In most cases, the cause is unknown but has been linked to smoking, exposure to petrochemical by-products, Hepatitis C, dialysis, and rare hereditary genetic predisposition.
In this “Hi Doc” CME Series II, we will cover surgical management of early RCC including minimally-invasive and nephron-sparing surgery. We will give an overview of medical management of RCC with the focus on immunotherapy and targeted therapy and share recent data of adjuvant immunotherapy for patients with high-risk early RCC.
Speakers
Senior Consultant
Medical Oncology
Parkway Cancer Centre
Senior Consultant
Urologist
FeM Surgery
This CME event is organised with FeM Surgery and supported by MSD.
DATE
Saturday, 27 July 2024
TIME
2PM - 3PM SGT
FORMAT
Hybrid Event
PHYSICAL MEETING REGISTRATION*
*Lunch will be served at 1pm. Seats are limited.
Breast lumps are abnormal growths that develop in the breast and are common. While most breast lumps are non-cancerous, they should not be ignored. Any lump in the breast should be investigated to eliminate the possibility of breast cancer.
In this “Hi Doc” CME Series II, we will share more about breast screening and how to address your patients’ queries. You will hear about the basics of screening, scan types and how to interpret mammogram and ultrasound reports..
We will evaluate common breast problems, discuss on the diagnosis of Breast Cancer, and share treatment updates (surgical/non-surgical).
Speakers
Senior Consultant
Medical Oncology
Parkway Cancer Centre
Senior Consultant and Breast Surgeon
Solis Breast Care and Surgery Centre
Consultant Radiologist
Luma Women's Imaging Centre
This CME event is in collaboration with Solis Breast Care and Surgery Centre.
DATE
Saturday, 13 July 2024
TIME
2PM - 3PM SGT
FORMAT
Hybrid Event
PHYSICAL MEETING REGISTRATION*
*Lunch will be served at 1pm. Seats are limited.
Lumps or swelling on the testicles (scrotal masses) are relatively common in boys and men and are usually benign. Testicular lumps and swelling can be a sign of an infection, hernia or swollen vein. But in rare cases, they may be a sign of cancer.
Testicular cancer is an uncommon cancer in men, but it is one of the most common cancers in young men aged 20-40 years old.
Nevertheless, the impact on an individual can be immense and can have long-lasting implications as it mainly involves young men in the prime of their lives.
In this “Hi Doc” CME Series II, we’ll be learning to recognise and diagnose testicular cancer as well as understanding the management of this cancer.
Speakers
Senior Consultant
Medical Oncology
Parkway Cancer Centre
Consultant
Urologist
Panasia Surgery
This CME event is in collaboration with Panasia Surgery.
DATE
Saturday, 6 April 2024
TIME
2PM - 3PM SGT
FORMAT
Hybrid Event
Learn About Cancer
Cancer Support
© 2024 Parkway Cancer Centre